Home › Kanser (lahat ng uri) › Texas › Irving

Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Irving, TX

14 pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Irving (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Nagre-recruitPhase 1/2

NEXT Oncology ( Site 1012), Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06818643

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Nagre-recruitPhase 1

NEXT Dallas, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07578571

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Dallas, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06959706

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

Nagre-recruitPhase 1

NEXT Oncology ( Site 0051), Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07247110

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Nagre-recruitPhase 1

NEXT Oncology Dallas, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07094204

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Nagre-recruitPhase 1/2

NEXT Oncology Dallas, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06162221

REC-7735 in Participants With Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology - Dallas, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07819136

Registry Study for Radiation Therapy Outcomes

Nagre-recruitObservasyonal na pag-aaral

Texas Center for Proton Therapy, Irving

Lahat ng edad · Lahat ng kasarian · Na-update Set 29, 2026 · NCT01255748

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

NEXT Dallas, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Dallas, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2026 · NCT05954312

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06014658

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

Nagre-recruitPhase 1

NEXT Oncology, Irving

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Dis 3, 2025 · NCT07021898

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Nagre-recruitPhase 1/2

NEXT Dallas, Irving

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2025 · NCT06090266

Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up

Nagre-recruitObservasyonal na pag-aaral

Texas Center for Proton Therapy, Irving

Lahat ng edad · Lahat ng kasarian · Na-update Peb 8, 2023 · NCT02070328

Pag-aaral para sa Kanser (lahat ng uri) sa ibang lungsod

Iba pang pag-aaral sa Irving

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.